| P50 | author | Jane E. Freedman | Q125127316 |
| P2093 | author name string | Lea M Beaulieu | |
| | Elaine Lin | |
| P2860 | cites work | Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina | Q79436666 |
| | Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury | Q79839081 |
| | Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction | Q79856753 |
| | In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk | Q80134207 |
| | Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9 | Q80492358 |
| | Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque | Q81444765 |
| | Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis | Q81453900 |
| | Evidence of Toll-like receptor molecules on human platelets | Q81479217 |
| | Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? | Q81947126 |
| | Immunology. Targeting the tolls | Q83154044 |
| | The danger model: a renewed sense of self | Q28214633 |
| | Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes | Q28280597 |
| | Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms | Q30319434 |
| | Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events | Q33318184 |
| | Platelets express functional Toll-like receptor-4. | Q33366814 |
| | Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium | Q33853586 |
| | Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. | Q35109063 |
| | Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. | Q36459911 |
| | Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. | Q36626556 |
| | Mechanisms of disease: Toll-like receptors in cardiovascular disease | Q36891895 |
| | Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction | Q36907993 |
| | Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland | Q36972703 |
| | Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis | Q36992344 |
| | Synthetic tetra-acylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4. | Q37476115 |
| | Expression of Toll-like receptors on human platelets | Q37866864 |
| | Risk of myocardial infarction and stroke after acute infection or vaccination | Q39471364 |
| | Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response | Q40217414 |
| | Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk | Q40609296 |
| | Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo | Q41969861 |
| | Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase | Q42137745 |
| | Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. | Q42514406 |
| | Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis | Q46092054 |
| | Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression | Q46433219 |
| | Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction | Q46687558 |
| | Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries | Q46878271 |
| | Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice | Q47200145 |
| | Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. | Q53531751 |
| | Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. | Q54534373 |
| | Local Overexpression of Toll-Like Receptors at the Vessel Wall Induces Atherosclerotic Lesion Formation | Q58482495 |
| | Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood | Q58831626 |
| | Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness | Q59981259 |
| | Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction | Q59981285 |
| | Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure | Q63341226 |
| | Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction | Q79255657 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| | toll-like receptor | Q408004 |
| P304 | page(s) | 117-123 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Cardiovascular Therapeutics | Q1871490 |
| P1476 | title | Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases | |
| P478 | volume | 27 | |